id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-3854-0006,FDA,FDA-2015-E-3854,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2019-07-03T04:00:00Z,2019,7,2019-07-03T04:00:00Z,,2019-07-03T15:32:14Z,,0,0,0900006483d5c52a
FDA-2015-E-3854-0005,FDA,FDA-2015-E-3854,"Determination of Regulatory Review Period for Purposes of Patent
Extension; BLINCYTO",Notice,Determinations,2018-02-07T05:00:00Z,2018,2,2018-02-07T05:00:00Z,2018-04-10T03:59:59Z,2018-02-07T17:30:37Z,2018-02419,0,0,0900006482ef7db3
FDA-2015-E-3854-0004,FDA,FDA-2015-E-3854,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:08:26Z,,0,0,0900006482433cb9
FDA-2015-E-3854-0003,FDA,FDA-2015-E-3854,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-02T05:00:00Z,2015,11,2015-11-02T05:00:00Z,,2016-05-11T15:50:10Z,,0,0,0900006481cfec36
FDA-2015-E-3854-0002,FDA,FDA-2015-E-3854,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T20:13:41Z,,0,0,0900006481cdab40
FDA-2015-E-3854-0001,FDA,FDA-2015-E-3854,"Patent Extension Application from Marshall, Gerstein & Borun, LLP (on behalf of  Amgen Research (Munich) GMBH)",Other,Application,2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T20:13:34Z,,0,0,0900006481cda9db